KUKJEON Co.,Ltd
Founded in 2018, KUKJEON supplies APIs through synthesis manufacturing and advanced materials like HBM additives for semiconductors and displays.
Price
Change
Market cap
Business overview
Source: DART corporate disclosureFounded and listed on KOSDAQ in 2018, KUKJEON is an API and advanced-materials company that renamed itself from Kukjeon Pharm to KUKJEON as its business expanded. Its pharmaceutical segment synthesizes, imports, distributes, and sells active pharmaceutical ingredients (APIs), while its materials segment supplies high-purity functional additives for HBM manufacturing, antistatic agents, and OLED common-layer materials for advanced industries. Its oral dementia drug candidate HY-209, in-licensed from Chaperone (378800), is nearing completion of Phase 1 trials, its hypertension-diabetes combination drug THP-001, co-developed with THPharm, is in Phase 3, and consolidated revenue fell 3.98% year-on-year.
Products & technology
- Active Pharmaceutical Ingredients (API)Synthesis manufacturing, import/distribution, and sale of APIs for generics, new drugs, and improved new drugs
- High-purity functional additives for HBM manufacturingMaterials for AI semiconductor packaging processes
- Antistatic agentsChemical materials for advanced industries
- OLED common-layer materialsMaterials for OLED displays
R&D and key agreements
Source: DART corporate disclosureHY-209(경구용 치매치료제) · 치매 · 임상1상 종료 예정 · In-licensed from Chaperone (378800) and co-developed
THP-001(고혈압·당뇨 복합제) · 고혈압, 당뇨 · 임상3상 · Co-developed with THPharm
제네릭 개발 프로젝트 · Multiple generic items under development in collaboration with client companies via the in-house pharmaceutical research institute
Companies in the same categoryPharma & CDMO
Founded and listed on the KOSPI in 2016, Il Dong Pharmaceutical manufactures products including the Aronamin vitamin line.
Founded in 1941 and listed on the KOSPI in 1975, Yuyu Pharma is a pharmaceutical company with a co-promotion agreement with Dong-A ST for Tanamin.
Founded in 1941 and listed on the KOSPI in 1975, Ildong Holdings is the holding company of the Ildong Pharmaceutical Group, overseeing pharmaceutical, aesthetic medical device, and drug development affiliates.
Founded 2000, KOSDAQ-listed 2009, Medy-Tox develops and exports botulinum toxin biopharmaceuticals including Meditoxin and Innotox.
KOSPI-listed comprehensive pharmaceutical company specializing in blood products and vaccines, with FDA-approved immunoglobulin ALYGLO.
Founded 2005, KOSDAQ-listed 2022, BIO-FD&C develops plant-cell platform-based cosmeceutical materials and biopharma pipelines.
KOSPI-listed pharmaceutical company behind Coldwon cold medicine and Jangdaewon probiotics, developing a P-CAB drug pipeline.
Founded 2011, listed 2016 — Samsung Biologics is a biopharma CDMO with 785,000L capacity across five Songdo plants.
Founded in 2006 and listed on KOSDAQ in 2020, Genolution is a molecular diagnostics and RNAi company producing nucleic acid extraction reagents and devices.
KOSPI-listed comprehensive pharma company behind Amaryl diabetes drug and the USD 86.25M HL5101 anticancer out-license deal.
Founded and listed on KOSDAQ in 2015, Kolmar BioTech is a nonclinical CRO providing efficacy testing for anticancer and metabolic disease drug candidates.
Sources and updates
- Company basics
- Korea Exchange · DART
- Business content
- Compiled from disclosure filings
- AI visibility
- Measured 2026-08-13
This page is compiled from public sources without the company's involvement. If anything is inaccurate or incomplete, please let us know. Materials provided by the company are labelled as such.
Request a correction or addition